EU official: Regulatory requirements for conditional marketing authorization ‘evolving’

Regulatory News

Regulatory NewsJoanne S. Eglovitch

Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsEuropePharmaceuticalsProduct developmentRegulatory Intelligence/Policy